Transperineal versus transrectal prostate fiducial insertion in radiation treatment of prostate cancer: a systematic review and meta-analysis
Source : https://pubmed.ncbi.nlm.nih.gov/38898635/
The use of both TP and TR techniques for placing gold seed fiducial markers has proven to be an effective, safe, and well-tolerated method for image-guided radiation therapy in prostate...
The use of both TP and TR techniques for placing gold seed fiducial markers has proven to be an effective, safe, and well-tolerated method for image-guided radiation therapy in prostate cancer patients. A significant benefit of the TP technique is its ability to avoid rectal puncture, thereby reducing the risk of UTIs. Although the incidence...
Metabolic Response to Androgen Deprivation Therapy of Prostate Cancer
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11171316/
Prostate cancer is the most common cancer in American men, aside from skin cancer, and it is the second deadliest. For patients with advanced or metastatic disease, systemic therapies are...
In conclusion, prostate cancer remains a significant health challenge, with its prevalence and mortality rate positioning it as a critical focus of oncological research and treatment. As prostate cancer progression is driven by androgens, ADT serves as the cornerstone of systemic treatment for advanced and metastatic prostate cancer. However,...
Prognostic value of 17-Gene genomic prostate score in patients with clinically localized prostate cancer
Source : https://pubmed.ncbi.nlm.nih.gov/38783246/
A higher 17-gene GPS significantly predicts distant metastases, biochemical recurrence, and PCSM in men with clinically localized prostate cancer. However, large-scale multicenter prospective studies are necessary to further validate these...
A higher 17-gene GPS significantly predicts distant metastases, biochemical recurrence, and PCSM in men with clinically localized prostate cancer. However, large-scale multicenter prospective studies are necessary to further validate these findings.
Men's Acceptance of Screening for Prostate Cancer with Prostate-specific Antigen, Magnetic Resonance Imaging, and Prostate Biopsy
Source : https://pubmed.ncbi.nlm.nih.gov/37993370/
We asked men how bothersome they found the prostate-specific antigen (PSA) test, magnetic resonance imaging (MRI), and prostate biopsies. Biopsies were more bothersome than PSA and MRI, but most men...
Biopsies are more bothersome than MRI, but a large majority of men accept to repeat both examinations if necessary. Omitting biopsy for MRI-negative men and shifting to targeted biopsies only will reduce bother for men participating in prostate cancer screening.
Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer
Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10921349/
Is relugolix, an oral androgen deprivation therapy, safe and effective in patients receiving radiotherapy for prostate cancer?In these 2 randomized clinical trials of 260 men with prostate cancer who were...
The results of these 2 randomized clinical trials suggest that relugolix rapidly achieves sustained castration in patients with localized and advanced prostate cancer receiving radiotherapy. No new safety concerns were identified when relugolix was used with radiotherapy.